David Sancho

28PUBLICATIONS
193CO-AUTHORS
Innate immunityTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 19, 2026
Metabolic support of trained immune responses in myeloid cells.

|May 22, 2026
Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells.

|Jan 13, 2026
ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis.

Annalaura Mastrangelo, Iñaki Robles-Vera, David Sancho

|Dec 12, 2025
A circadian checkpoint relocates neutrophils to minimize injury.

Alejandra Aroca-Crevillén, Sandra Martín-Salamanca, Lidiane S Torres

|Nov 25, 2025
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection.

Elena Hernández-García, Miguel Galán, Sofía C Khouili

|Jul 16, 2025
Imidazole propionate is a driver and therapeutic target in atherosclerosis.

Annalaura Mastrangelo, Iñaki Robles-Vera, Diego Mañanes

Pageof 5

Frequent Collaborators

6 joint publications

Salvador Iborra

6 joint publications

Steffanie K Wculek

5 joint publications

Annalaura Mastrangelo

4 joint publications

Elena Hernández-García